Pathophysiology of interstitial cystitis

Current Opinion in Obstetrics and Gynecology

Volumn 12, Issue 5, 2000, Pages 405-410

  Rosamilia, Anna ^a,b   Dwyera, Peter L ^a,c,d  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c MERCY HOSPITAL FOR WOMEN   (Australia)

^d NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; INTERSTITIAL CYSTITIS; PATHOPHYSIOLOGY; REVIEW;

CYSTITIS, INTERSTITIAL; FEMALE; HUMANS;

EID: 0034302973     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200010000-00010     Document Type: Article

References (66)

1. Hunner GL. A rare type of bladder ulcer. Further notes with a report of eighteen cases. JAMA 1918; 70:203-213.
2. •] from one of the most senior authors in the field.
3. Held PJ, Hanno PM, Wein AJ, et al. Epidemiology of interstitial cystitis. In: Interstitial cystitis. Hanno P, Staskin DR, Krane RJ, et al. ( editors). New York: Springer-Verlag; 1990. pp. 29-48.
4. Curhan GC, Speizer FE, Hunter DJ, et al. Epidemiology of interstitial cystitis: a population based study. J Urol 1999; 161:549-552. This epidemiological survey used the Nurses Health Study Group studies (NHS I and II) and confirmed current prevalence rates of IC.
5. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis. J Urol 1988; 140:203-206.
6. Johansson SL, Fall M. Pathology of interstitial cystitis. Urol Clin North Am 1994; 21:55-62.
7. Lynes WL, Flynn SD, Shortliffe LD, et al. The histology of interstitial cystitis. Am J Surg Pathol 1990; 14:969-976.
8. Rosamilia A, Cann L, Dwyer P, et al. Bladder microvasculature in women with interstitial cystitis. J Urol 1999; 161:1865-1870. Women with IC were found to have a reduced subepithelial blood vessel density. If confirmed, this may explain some of the clinical and pathological findings of IC.
9. Hanno PM, Landis JR, Matthews-Cook Y, et al., and The Interstitial Cystitis Database Study Group. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database Study. J Urol 1999; 161:553-557. The NIDDK research definition is too strict for clinical use.
10. Waxman JA, Sulac PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 1998; 160:1663-1667.
11. Rosamilia A, Dwyer PL. Interstitial cystitis and the gynecologist. Obstet Gynecol Surv 1998; 53:309-319.
12. Domingue GJ, Ghoniem GM, Bost KL, et al. Dormant microbes in interstitial cystitis. J Urol 1995; 153:1321-1326.
13. Haarala M, Jalava J, Laato M, et al. Absence of bacterial DNA in the bladder of patients with interstitial cystitis. J Urol 1996; 156:1843-1845.
14. Keay S, Zhang CO, Baldwin BR, et al. Polymerase chain reaction amplification of bacterial 16S rRna genes in interstitial cystitis and control patient bladder biopsies. J Urol 1998; 159:280-283.
15. Haarala M, Kiilholma P, Lehtonen O-P. Urinary bacterial flora of women with urethral syndrome and interstitial cystitis. Gynecol Obstet Invest 1999; 47:42-44.
16. English SF, Liebert M, Cross CA, McGuire EJ. The incidence of Heliobacter pylori in patients with interstitial cystitis. J Urol 1998; 159:772-773.
17. Duncan JL, Schaeffer AJ. Do infectious agents cause interstitial cystitis? Urology 1997; 49(Suppl 5A):48-51.
18. Parsons CL. Interstitial cystitis. In: Female urology. Kursh ED, McGuire EJ (editors). Philadelphia: JB Lippincott; 1994. pp.421-438.
19. Wilson CB, Leopard J, Nakamura RM, et al. Selective type IV collagen defects in the urothelial basement membrane in interstitial cystitis. J Urol 1995; 154:1222-1226.
20. Hurst RE, Roy JB, Min KW, et al. Deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urol 1996; 48:817-821.
21. Erickson DR, Sheykhnazari M, Ordille S, Bhavanandan VP. Increased urinary hyaluronic acid and interstitial cystitis. J Urol 1998; 160:1282-1284.
22. Ruggieri MR, Chelsky MJ, Rosen SI, et al. Current findings and future research avenues in the study of interstitial cystitis. Urol Clin North Am 1994; 21:163-176.
23. Dixon JS, Holm-Benzten M, Gilpin C, et al. Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis. J Urol 1986; 135:621-625.
24. Nickel JC, Emerson L, Cornish J. The bladder mucus (glycosaminoglycan) layer in interstitial cystitis. J Urol 1993; 149:716-718.
25. Byrne DS, Sedor JF, Estojak J, et al. The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol 1999; 161:1786-1790. This paper presents the exciting finding of a marker of loss of glycosaminoglycan layer component. The urine assay has a potential role as a diagnostic test and one that could monitor response to therapy.
26. Gillespie L, Said J, Cain W, et al. Antibiotic-induced interstitial cystitis: a model for cell membrane instability [abstract]. J Urol 1985; 133:177A.
27. Parsons CL, Greenberger M, Gabal L, et al. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998; 159:1862-1867.
28. Teichman JMH, Nielsen-Omeis BJ. Potassium leak test predicts outcome in interstitial cystitis. J Urol 1999; 161:1791-1796. This study is interesting, but methodological problems include responder bias.
29. •].
30. Chambers GK, Fenster HN, Cripps S, et al. An assessment of the use of intravesical potassium in the diagnosis of interstitial cystitis. J Urol 1999; 162:699-701. This paper suggests that the potassium sensitivity test has a poor positive and negative predictive value.
31. Keay S, Warren JW, Zhang CO, et al. Antiproliferative activity is present in bladder but not renal pelvic urine from interstitial cystitis patients. J Urol 1999; 162:1487-1489. This paper reports the intriguing finding of an inhibitory factor to bladder epithelial growth in urine of IC patients; there are many potential candidates.
32. Alagiri M, Chottiner S, Ratner V, et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997; 49(Suppl 5A):52-57.
33. Van de Merwe J, Kamerling R, et al. Sjögren's syndrome in patients with interstitial cystitis. J Rheumatol 1993; 20:962-966.
34. Ratliff TL, Klutke CG, Hofmeister M, et al. Role of the immune response in interstitial cystitis. Clin Immunol Immunopathol 1995; 74:209-216.
35. Matilla J. Vascular immunopathology in interstitial cystitis. Clin Immunol Immunopathol 1982; 23:648-655.
36. Liebert M, Wedemeyer G, Stein J, et al. Evidence for urothelial cell activation in interstitial cystitis. J Urol 1993; 149:470-475.
37. Lotz M, Villiger P, Hugli T, et al. Interleukin-6 and interstitial cystitis. J Urol 1994; 152:869-873.
38. Liebert M, Wedemeyer G, Stein J, et al. Cytokine profiles in interstitial cystitis [abstract]. J Urol 1994; 151:283A.
39. Martins SM, Darlin DJ, Lad PM, Zimmern PE. Interleukin-1B: a clinically relevant urinary marker. J Urol 1994; 151:1198-1201.
40. Miller CH, MacDermott JP, Quattrocchi KB, et al. Lymphocyte function in patients with interstitial cystitis. J Urol 1992; 147:592-595.
41. Steinert BW, Diokno AC, Robinson JE, Mitchell BA. Complement C3, eosinophil cationic protein and symptom evaluation in interstitial cystitis. J Urol 1994; 151:350-354.
42. Buffington CA, Chew DJ, Woodworth BE. Idiopathic cystitis in cats: an animal model of interstitial cystitis. In: Interstitial cystitis. Sant GR (editor). Philadelphia: Lippincott-Raven; 1997. pp. 25-31.
43. Buffington CA, Chew DJ, Woodworth BE. Feline interstitial cystitis. J Am Vet Med Assoc 1999; 215:682-687. This is an entertaining and informative overview of IC in cats, which draws many analogies with human IC.
44. Peters K, Diokno A, Steinert B, et al. The efficacy of intravesical Tice strain bacillus calmette-guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol 1997; 157:2090-2094.
45. Peters K, Diokno A, Steinert B, Gonzalez JA. The efficacy of intravesical Tice strain bacillus calmette - guerin in the treatment of interstitial cystitis: long-term follow up. J Urol 1998; 159:1483-1487.
46. Peters KM, Diokno AC, Steinert BW. Preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical bacille Calmette - Guérin treat interstitial cystitis by altering the immune profile in the bladder? Urology 1999; 54:450-453. Raised urinary cytokines suggest an immunological basis in IC and in BCG therapy for IC.
47. Steers WD, Tuttle JB. Neurogenic inflammation and nerve growth factor: possible roles in interstitial cystitis. In: Interstitial cystitis. Sant GR (editor). Philadelphia: Lippincott-Raven; 1997. pp 67-75.
48. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997; 49(Suppl 5A):14-40.
49. Theoharides CT, Sant GR. The mast cell as a neuroimmunoendocrine effector in interstitial cystitis. In: Interstitial cystitis. Sant GR (editor). Philadelphia: Lippincott-Raven; 1997. pp. 101-108.
50. Hohenfellner M, Nunes L, Schmidt RA, et al. Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J Urol 1992; 147:587-591.
51. Sant GR, Theoharides TC. The role of the mast cell in interstitial cystitis. Urol Clin North Am 1994; 21:41-53.
52. Pang X, Cotreau-Bibbo MM, Sant GR, Theoharides TC. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br J Urol 1995; 75:154-161.
53. Letourneau R, Pang X, Sant GR, Theoharides TC. Intragranular activation of mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 1996; 77:41-54.
54. Christmas TJ, Rode J. Characteristics of mast cells in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol 1991; 68:473-478.
55. Pang X, Marchand J, Sant GR, et al. Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 1995; 75:744-750.
56. Nilsson G, Forsberg-Nilsson, Xiang Z, et al. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997; 27:2295-29301.
57. Lowe EM, Anand P, Terenghi G, et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997; 79:572-577.
58. Okragly AJ, Niles AL, Saban R, et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 1999; 161:438-442. This small series draws together increased mast cell and neuronal involvement, further supporting the hypothesis of neurogenic inflammation.
59. Smith SD, Wheeler MA, Foster Jr HE, Weiss RM. Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections. J Urol 1996; 155:1432-1435.
60. Korting GE, Smith SD, Wheeler MA, et al. A randomised double-blind trial of oral L-arginine for the treatment of interstitial cystitis. J Urol 1999; 161:558-565. This well-conducted trial showed no difference between L-arginine and placebo using an intention-to-treat analysis. However, per protocol analysis confirmed some symptomatic improvement.
61. Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 1993; 16:99-104.
62. Zuraw BL, Sugimoto S, Parsons CL, et al. Activation of urinary kallikrein in patients with interstitial cystitis. J Urol 1994; 152:874-878.
63. Rosamilia A, Clements JA, Dwyer PL, et al. Activation of the kallikrein-kinin system in interstitial cystitis. J Urol 1999; 162:129-134. Evidence is provided for involvement of another inflammatory mediator, with results suggesting a bladder contribution to the increase in excretion of circulating bradykinin.
64. Irwin PP, Galloway TM. Interstitial cystitis: the neurovascular perspective. In: Interstitial cystitis. Sant G (editor). Philadelphia: Lippincott-Raven; 1997. pp. 129-135.
65. Pontari MA, Hanno PM, Ruggieri MR. Comparison of bladder blood flow in patients with and without interstitial cystitis. J Urol 1999; 162:330-334. Further support for the association between IC and reduced vascularity is provided.
66. Stein PC, Torri A, Parsons CL. Elevated urinary norepinephrine in interstitial cystitis. Urology 1999; 53:1140-1143. An interesting finding is described that suggests increased sympathetic activity in IC.